NORBASKIN

This brand name is authorized in Nigeria.

Active ingredients

The drug NORBASKIN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII R9400W927I - KETOCONAZOLE
 

Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes.

 
Read more about Ketoconazole
2
UNII 779619577M - CLOBETASOL PROPIONATE
 

Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid.

 
Read more about Clobetasol propionate
3
UNII 057Y626693 - NEOMYCIN SULFATE
 

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

 
Read more about Neomycin
4
UNII H4N855PNZ1 - .ALPHA.-TOCOPHEROL
 

Vitamin E is known to exert an important physiological function as an antioxidant for fats, with a sparing action on vitamin A, carotenoids and on unsaturated fatty acids. Other work has demonstrated that vitamin E is connected with the maintenance of certain factors essential for the normal metabolic cycle.

 
Read more about Vitamin E

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100674 Cream NORBASKIN CREAM 30GM CREAM 10mg; 0.25mg; 5mg 1 X 30g 44 NF-PP-339013 NORBASKIN CREAM 30GM KETOCONAZOLE 10MG, CLOBETASOL PROPIONATE 0.25MG, NEOMYCIN SULPHATE 5000IU, VITAMIN E KETOCONAZOLE 10MG, CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE 5000IU A4-100674 Drugs Imported Products 130g Over The Counter (OTC) 7/3/2023 NORBARC PHARMACEUTICAL LIMITED, NO. 7 ABEOKUTA STREET EBUTE META 7036535830 norbarcpharm@yahoo.com MARINE LIFE SCIENCES., PLOT NO.30 PHASE III (EXT) HPSIDC, BADDI DSTT. SOLAN (H.P) INDIA, India 21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D07CD01 Clobetasol and antibiotics D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CD Corticosteroids, very potent, combinations with antibiotics
Discover more medicines within D07CD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100674

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.